Chunna T. Ma

Beijing, 100069, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Vaccine Effectiveness Estimates Against Influenza A(H3N2)-Associated Hospitalized Severe Acute Respiratory Infections in Beijing, China, 2025/26 Influenza Season.

Vaccine Effectiveness Estimates Against Influenza A(H3N2)-Associated Hospitalized Severe Acute Respiratory Infections in Beijing, China, 2025/26 Influenza Season.

Journal: Vaccines

Published: April 13, 2026

Influenza Vaccine Effectiveness in School Outbreaks During a A(H3N2) Subclade K (J.2.4.1)-Dominated Season in Beijing, China, 2025-26.

Influenza Vaccine Effectiveness in School Outbreaks During a A(H3N2) Subclade K (J.2.4.1)-Dominated Season in Beijing, China, 2025-26.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: March 04, 2026

Modest protection from vaccination against influenza A(H3N2) subclade K, Beijing, China, 2025/26 season.

Modest protection from vaccination against influenza A(H3N2) subclade K, Beijing, China, 2025/26 season.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: February 20, 2026

Moderate protection from vaccination against influenza A(H3N2) subclade K in Beijing, China, September to December 2025.

Moderate protection from vaccination against influenza A(H3N2) subclade K in Beijing, China, September to December 2025.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: January 16, 2026

Phylogenetic and Molecular Characteristics of An H3N8 Avian Influenza Virus Detected in Wild Birds - Beijing, China, September 2024.

Phylogenetic and Molecular Characteristics of An H3N8 Avian Influenza Virus Detected in Wild Birds - Beijing, China, September 2024.

Journal: China CDC weekly

Published: August 25, 2025

Influenza Vaccine Effectiveness Against Influenza A(H1N1)pdm09-Associated Hospitalizations With SARI in Beijing, China, in the 2024-2025 Season.

Influenza Vaccine Effectiveness Against Influenza A(H1N1)pdm09-Associated Hospitalizations With SARI in Beijing, China, in the 2024-2025 Season.

Journal: Influenza and other respiratory viruses

Published: June 12, 2025

End-of-Season Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza in Outpatient Settings, Beijing, China: A Test-Negative Design.

End-of-Season Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza in Outpatient Settings, Beijing, China: A Test-Negative Design.

Journal: Vaccines

Published: June 11, 2025

Early vaccine effectiveness estimates against medically attended laboratory-confirmed influenza based on influenza surveillance, Beijing, China, 2024/25 season.

Early vaccine effectiveness estimates against medically attended laboratory-confirmed influenza based on influenza surveillance, Beijing, China, 2024/25 season.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: February 21, 2025

Vaccine effectiveness against influenza B/Victoria-associated medically attended influenza-like illness: Beijing, China, 2021-2022 influenza season.

Vaccine effectiveness against influenza B/Victoria-associated medically attended influenza-like illness: Beijing, China, 2021-2022 influenza season.

Journal: Human vaccines & immunotherapeutics

Published: February 19, 2025

Influenza Vaccine Effectiveness against Influenza A-Associated Outpatient and Emergency-Department-Attended Influenza-like Illness during the Delayed 2022-2023 Season in Beijing, China.

Influenza Vaccine Effectiveness against Influenza A-Associated Outpatient and Emergency-Department-Attended Influenza-like Illness during the Delayed 2022-2023 Season in Beijing, China.

Journal: Vaccines

Published: August 21, 2024

Moderate effectiveness of influenza vaccine in outpatient settings: A test-negative study in Beijing, China, 2023/24 season.

Moderate effectiveness of influenza vaccine in outpatient settings: A test-negative study in Beijing, China, 2023/24 season.

Journal: Vaccine

Published: August 07, 2024

Mitigated transmission and health impact of COVID-19 in Beijing, China during spring 2024: Comparison with the global trends.

Mitigated transmission and health impact of COVID-19 in Beijing, China during spring 2024: Comparison with the global trends.

Journal: Science bulletin

Published: March 31, 2024

Showing 1-12 of 43

Last Updated: 09/26/2026